blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0465097

EP0465097 - Peptides having atrial natriuretic factor activity [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  30.06.1994
Database last updated on 03.09.2024
Most recent event   Tooltip30.06.1994Application deemed to be withdrawnpublished on 17.08.1994 [1994/33]
Applicant(s)For all designated states
Merck & Co., Inc.
126, East Lincoln Avenue P.O. Box 2000 Rahway
New Jersey 07065-0900 / US
[N/P]
Former [1992/02]For all designated states
MERCK & CO. INC.
126, East Lincoln Avenue P.O. Box 2000
Rahway New Jersey 07065-0900 / US
Inventor(s)01 / Nutt, Ruth F.
775 Hill Road
Green Lane, PA 18054 / US
02 / Veber, Daniel F.
290 Batleson Road
Ambler, PA 19002 / US
03 / Brady, Stephen F.
8803 Crefeld Street
Philadelphia, PA 19118 / US
04 / Williams, Theresa M.
260 Shadynook Road
Harleysville, PA 19438 / US
[1992/02]
Representative(s)Thompson, John, et al
Merck & Co., Inc. European Patent Department Terlings Park Eastwick Road
Harlow, Essex CM20 2QR / GB
[N/P]
Former [1992/02]Thompson, John Dr., et al
Merck & Co., Inc. European Patent Department Terlings Park Eastwick Road
Harlow, Essex CM20 2QR / GB
Application number, filing date91305746.925.06.1991
[1992/02]
Priority number, dateUS1990054362126.06.1990         Original published format: US 543621
[1992/02]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP0465097
Date:08.01.1992
Language:EN
[1992/02]
Type: A3 Search report 
No.:EP0465097
Date:24.03.1993
Language:EN
[1993/12]
Search report(s)(Supplementary) European search report - dispatched on:EP01.02.1993
ClassificationIPC:C07K7/08, C07K7/10, A61K37/24
[1992/02]
CPC:
A61P7/10 (EP); A61P9/00 (EP); A61P9/08 (EP);
A61P9/12 (EP); C07K14/58 (EP); A61K38/00 (EP)
Designated contracting statesCH,   DE,   FR,   GB,   IT,   LI,   NL [1992/02]
TitleGerman:Peptide mit einer Aktivität des atrialen natriuretischen Faktors (ANF)[1992/02]
English:Peptides having atrial natriuretic factor activity[1992/02]
French:Peptides ayant une activité du facteur natriurétique atrial (ANF)[1992/02]
File destroyed:03.09.2001
Examination procedure25.09.1993Application deemed to be withdrawn, date of legal effect  [1994/33]
01.02.1994Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time  [1994/33]
Fees paidPenalty fee
Penalty fee Rule 85b EPC 1973
04.11.1993M01   Not yet paid
Additional fee for renewal fee
30.06.199303   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO8910935  (ABBOTT LAB [US]);
 [X]EP0269299  (NOVO INDUSTRI AS [DK]);
 [A]EP0292257  (MERCK & CO INC [US]);
 [A]EP0292256  (MERCK & CO INC [US])
 [X]  - PEPTIDE CHEMISTRY, PROC. 25TH SYMP. PEPT. CHEM., KOBE (JP), 28-9/2-10-1987T. SHIBA
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.